Abstract
Antiinflammatory dendritic polyglycerol sulfate (dPGS) holds great potential in the treatment and imaging of inflammatory processes. Here, we studied its biokinetic behavior, biodistribution, target cells, and in vivo toxicology. Following intravenous or subcutaneous application of 35sulfur-labeled dPGS amine with a molecular weight of 10.05 kDa and a hydrodynamic diameter of 5.7 ± 1.5 nm to mice, tissues were collected at specific time points (2, 15 min; 1, 24 h; 5, 21 days) and analyzed by liquid scintillation counting, autoradiography, radioluminography, and light microscopic autoradiography. The blood half-life of dPGS amine was 12 days. The major route of elimination was via the bile and feces. Elimination via the kidney and urine was only initially observed after i.v., but not after s.c. injection. Regardless of the administration mode, liver and spleen were late target organs where dPGS amine accumulated in phagocytic cells. Despite bioaccumulation, toxicological histopathology failed to identify any adverse effects at any time and in any tissues examined suggesting a high in vivo biocompatibility and encouraging future investigation for biomedical applications.
Similar content being viewed by others
Abbreviations
- C max :
-
Maximum concentration
- dPGS:
-
Dendritic polyglycerol sulfate
- HE:
-
Hematoxylin and eosin
- ID:
-
Injected dose
- i.v.:
-
Intravenous
- LMA:
-
Light microscopic autoradiography
- LSC:
-
Liquid scintillation counting
- MPS:
-
Mononuclear phagocyte system
- NP:
-
Nanoparticle
- p.a.:
-
Post administration
- PSP:
-
Photostimulable phosphor plate
- s.c.:
-
Subcutaneous
- SD:
-
Standard deviation
- SOA:
-
Single-organ autoradiography
References
Atkins GL (1974) Multicompartment models for biological systems. Methuen, Chapman and Hall
Bancroft JD, Gamble M (2007) Theory and practice of histological techniques, 6th edn. Churchill Livingstone Elsevier, London
Biffi S et al (2013) Dendritic polyglycerolsulfate near infrared fluorescent (NIRF) dye conjugate for non-invasively monitoring of inflammation in an allergic asthma mouse model. PLoS One 8:e57150. doi:10.1371/journal.pone.0057150
Calderón M, Quadir MA, Sharma SK, Haag R (2010) Dendritic Polyglycerols for Biomedical Applications. Adv Mater 22:190–218. doi:10.1002/adma.200902144
Cho M et al (2009) The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 189:177–183. doi:10.1016/j.toxlet.2009.04.017
Dernedde J et al (2010) Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation. Proc Natl Acad Sci USA 107:19679–19684. doi:10.1073/pnas.1003103107
Fox ME, Szoka FC, Fréchet JMJ (2009) Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res 42:1141–1151. doi:10.1021/ar900035f
Gröger D et al (2013) Synthesis and biological evaluation of radio and dye labeled amino functionalized dendritic polyglycerol sulfates as multivalent anti-inflammatory compounds. Bioconjug Chem 24:1507–1514. doi:10.1021/bc400047f
Holzhausen C, Gröger D, Mundhenk L, Welker P, Haag R, Gruber AD (2013) Tissue and cellular localization of nanoparticles using 35S labeling and light microscopic autoradiography. Nanomedicine 9:465–468
Jani P, Nomura T, Yamashita F, Takakura Y, Hashida M, Florence A (1996) Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male Wistar rats. J Drug Target 4:87–93. doi:10.3109/10611869609046266
Jock Thomson PBC (2001) Use and preparation of quench curves in liquid scintillation counting. http://www.ehs.psu.edu/radprot/Packard_quench_curves_calibration.pdf. Accessed 18 Jun 2013
Kainthan RK, Brooks DE (2007) In vivo biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials 28:4779–4787. doi:10.1016/j.biomaterials.2007.07.046
Khandare J, Mohr A, Calderón M, Welker P, Licha K, Haag R (2010) Structure-biocompatibility relationship of dendritic polyglycerol derivatives. Biomaterials 31:4268–4277. doi:10.1016/j.biomaterials.2010.02.001
Kolbe H, Dietzel G (2000) Technical validation of radioluminography systems. Regul Toxicol Pharmacol 31:S5–S14. doi:10.1006/rtph.2000.1380
Levy G, Gibaldi M, Jusko WJ (1969) Multicompartment pharmacokinetic models and pharmacologic effects. J Pharm Sci 58:422–424. doi:10.1002/jps.2600580406
Li S-D, Huang L (2008) Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5:496–504. doi:10.1021/mp800049w
Licha K et al (2011) Fluorescence imaging with multifunctional polyglycerol sulfates: novel polymeric near-IR probes targeting inflammation. Bioconjug Chem 22:2453–2460. doi:10.1021/bc2002727
Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3:703–717. doi:10.2217/17435889.3.5.703
Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265–14270. doi:10.1073/pnas.0805135105
Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nano Today 3:40–47. doi:10.1016/s1748-0132(08)70014-8
Marquis BJ, Love SA, Braun KL, Haynes CL (2009) Analytical methods to assess nanoparticle toxicity. Analyst 134:425–439
Müller RH, Wallis KH (1993) Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908. Int J Pharm 89:25–31. doi:10.1016/0378-5173(93)90304-x
Müller RH, Rühl D, Lück M, Paulke BR (1997) Influence of fluorescent labelling of polystyrene particles on phagocytic uptake surface hydrophobicity, and plasma protein adsorption. Pharm Res 14:18–24. doi:10.1023/a:1012043131081
Nel AE et al (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543–557
Owens Iii DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102. doi:10.1016/j.ijpharm.2005.10.010
Quadir MA, Haag R (2012) Biofunctional nanosystems based on dendritic polymers. J Control Release 161:484–495. doi:10.1016/j.jconrel.2011.12.040
Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, Larsen A, Danscher G (2007) Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4:10
Sadauskas E, Danscher G, Stoltenberg M, Vogel U, Larsen A, Wallin H (2009) Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 5:162–169
Toutain PL, Bousquet-MÉLou A (2004) Plasma terminal half-life. J Vet Pharmacol Ther 27:427–439. doi:10.1111/j.1365-2885.2004.00600.x
Van Aubel RAMH, Masereeuw R, Russel FGM (2000) Molecular pharmacology of renal organic anion transporters. Am J Physiol Renal Physiol 279:F216–F232
Weinhart M, Gröger D, Enders S, Dernedde J, Haag R (2011a) Synthesis of dendritic polyglycerol anions and their efficiency toward L-selectin inhibition. Biomacromolecules 12:2502–2511. doi:10.1021/bm200250f
Weinhart M et al (2011b) The role of dimension in multivalent binding events: structure-activity relationship of dendritic polyglycerol sulfate binding to L-selectin in correlation with size and surface charge density. Macromol Biosci 11:1088–1098. doi:10.1002/mabi.201100051
Yamaoka T, Tabata Y, Ikada Y (1994) Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci 83:601–606. doi:10.1002/jps.2600830432
Acknowledgments
We thank Adelheid Hagenbach and Ulrich Abram for support by the Liquid Scintillation Counting technique and construction of radioactive dPG35S amine as well as Nancy A. Erickson for helpful discussions.
This work was supported by the Helmholtz Virtual Institute on “Multifunctional Polymers in Medicine” and the FU Focus Area “Nanoscale”, the collaborative research centers SFB 765 and SFB 1112 (A02, C03) of the German Science Foundation (DFG) and the DFG Priority Program 1313 Biological Responses to Nanoscale Particles.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Cornelia Holzhausen: this article is part of the Ph.D thesis of CH.
Rights and permissions
About this article
Cite this article
Holzhausen, C., Gröger, D., Mundhenk, L. et al. Biodistribution, cellular localization, and in vivo tolerability of 35S-labeled antiinflammatory dendritic polyglycerol sulfate amine. J Nanopart Res 17, 116 (2015). https://doi.org/10.1007/s11051-015-2927-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-015-2927-3